Pharmaceutical

Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation

The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and Wegovy.

May 19, 2024 - 04:00
Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation
The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and Wegovy.
Read the original article

Tags:

Previous Article

J&J expands dermatology portfolio with $850m Proteologix acquisition

Next Article

Erasca trims workforce and pipeline to focus on KRAS and molecular glues

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ransomware attack shuts down hospital emergency rooms in several states

Ransomware attack shuts down hospital emergency rooms i...

Aug 9, 2023

STAT+: For hospitals after No Surprises Act, physician subsidies are ‘the new contract labor’

STAT+: For hospitals after No Surprises Act, physician ...

Oct 30, 2023

Sterilisation Solutions, Equipment and Services for the Pharmaceutical Industry

Sterilisation Solutions, Equipment and Services for the...

Oct 2, 2024